Circulating Tumor Cell Enumeration and Characterization in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Cabazitaxel

(1) Background: Markers identifying which patients with metastatic, castration-resistant prostate cancer (mCRPC) will benefit from cabazitaxel therapy are currently lacking. Therefore, the aim of this study was to identify markers associated with outcome to cabazitaxel therapy based on counts and ge...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancers (Basel)
Egile Nagusiak: de Kruijff, Ingeborg E., Sieuwerts, Anieta M., Onstenk, Wendy, Kraan, Jaco, Smid, Marcel, Van, Mai N., van der Vlugt-Daane, Michelle, Oomen-de Hoop, Esther, Mathijssen, Ron H.J., Lolkema, Martijn P., de Wit, Ronald, Hamberg, Paul, Meulenbeld, Hielke J., Beeker, Aart, Creemers, Geert-Jan, Martens, John W.M., Sleijfer, Stefan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6721462/
https://ncbi.nlm.nih.gov/pubmed/31434336
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11081212
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak